PDL BioPharma (PDLI) Reports New $100M Share Buyback
PDL BioPharma, Inc. (NASDAQ: PDLI) announces its Board of Directors has authorized a new stock repurchase program to acquire ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)